Safety, Tolerability and Pharmacokinetics Study of CK-3773274
Status:
Completed
Trial end date:
2021-08-05
Target enrollment:
Participant gender:
Summary
The purposes of this study are to:
1. Learn about the safety of CK-3773274 after a single dose and multiple doses in Chinese
healthy adult subjects.
2. Learn how healthy subjects tolerate CK-3773274 after a single dose and multiple doses.
3. Find out how much CK-3773274 is in the blood after a single dose and multiple doses.
4. Determine the effect of doses of CK-3773274 on the pumping function of the heart.
5. Evaluate the effect CYP2D6 genetic polymorphisms on how the body metabolizes CK-3773274.